Tolerance and Autoimmunity Flashcards

1
Q

Immunologic Tolerance Definition

A

Ability of an individual to ignore “self” while reacting to “non-self” antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Central Tolerance

A
  • T and B cell development events (negative selection)
  • Restricted to primary organ (thymus and bone marrow)
  • Majority of mature cells react ONLY with foreign Ag (bc they are tolerant)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Peripheral Tolerance

A
  • Mature T cell and B cell event in periphery
  • Restricted to secondary organs (spleen, lymph node, and non-lymphoid tissue)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Central Tolerance Mechanisms

A
  • T Cells: Clonal Deletion (positive/negative selection)
  • B Cells: Clonal Deletion, Anergy, Receptor editing
  • Clonal Diversion: Self-reactive Th cells become regulatory T cells
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Outcome of Positive Selection (T Cell)

A

Attention of T cell focused on recognizing MHC-self peptide complex and not just free Ag

Weakly interacting cells survive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Outcome of Positive Selection (T Cell)

A

Attention of T cell focused on recognizing MHC-self peptide complex and not just free Ag

Weakly interacting cells survive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Outcome of Negative Selection (T Cell)

A

T cells that recognize self-Ag are eliminated

Strongly interacting cells die off

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Avidity Definition (B Cell)

A

Strength of Interaction

Determined By:

Affinity of BCR and self-Ag

Density of BCR

Nature of self-Ag (membrane bound vs soluble Ag)

Concentration of self-Ag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to B cell with high avidity?

A

Deletion/Receptor Editing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What happens to B cell with high avidity?

A

Deletion/Receptor Editing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What happens to B cell with moderate avidity?

A

Anergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What happens to B cell with moderate avidity?

A

Anergy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens to B cell with low avidity?

A

Clonal ignorance (no threat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What happens to B cell with low avidity?

A

Clonal ignorance (no threat)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why is peripheral tolerance needed?

A

Some mature T cells will:

have a TCR that can respond to self-Ag

Encounter high self Ag that overwhelms TCR

Encounter strong secondary signals in response to infection

This is why we need peripheral tolerance to maintain tolerance throughout body

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Peripheral Tolerance Mechanisms

A
  • Anergy
  • Deletion
  • Regulatory T cell (will inactivate other lymphocytes specific for the same self-Ag it is)
  • Immune privilege sites (certain tissues that will kill rogue cells (brain, eye, ovary, placenta, testes)
13
Q

Bcl2/Bim mediated apoptosis

A

imbalanced expression or pro-apoptotic proteins, destabilizes mitochondrial membrane resulting in apoptosis.

14
Q

Fas mediated apoptosis

A

Engagement of death receptors

15
Q

When can Tolerance be a bad thing?

A

Undesirable tolerance of tumors

16
Q

Does induced tolerance last forever?

A

No, with time it wanes and eventually disappears

17
Q

Autoimmunity Definition

A

Failure of self-tolerance mechanism(s) that results in an immune response against “self”

18
Q

Autoimmunity Causes

A

Multiple Gene Defects (rarely caused by single gene defect)

Exception: defect in Fas/FasL, AIRE, FOXp3 expression

19
Q

Disease: APS-1 (single gene defect)

A

Gene: AIRE (autoimmune regulator)

Mechanism: Decreased expression of self-antigens in the thymus (neg selection)

19
Q

Disease: APS-1 (single gene defect)

A

Gene: AIRE (autoimmune regulator)

Mechanism: Decreased expression of self-antigens in the thymus (neg selection)

20
Q

Disease: IPEX (single gene defect)

A

Gene: FOXP3

Mechanism: decreased generation of Tregs

21
Q

Disease: ALPS (single gene defect)

A

Gene: FAS, FASL

Mechanism: Failure of apoptotic death of self reactive T or B cells

21
Q

Disease: ALPS (single gene defect)

A

Gene: FAS, FASL

Mechanism: Failure of apoptotic death of self reactive T or B cells

22
Q

Environmental causes of Autoimmunity

A
  • Inducing the release of sequestered self-Ag (trauma)
  • Induction due to infection
    • Molecular Mimicry
23
Q

Molecular Mimicry Example: Rheumatic Fever

A

Host Antigens: Cardiac myosin, tropomyosin, keratin

Pathogens: Streptococcus pyogenes

24
Q

Organ Specific Autoimmunity Examples

A
  • Type I Diabetes
  • Goodpasture’s syndrome
  • Multiple sclerosis
  • Graves’ disease
  • Hashimoto’s thyroiditis
  • Autoimmune hemolytic anemia
  • Myasthenia gravis
25
Q

Systemic Autoimmunity Examples

A
  • Rheumatoid Arthritis
  • Systemic Lupus
  • Sjogren’s syndrome
26
Q

What are the main mechanisms of autoimmunity?

A

Antibody mediated or T cell mediated (CD4 or CD8)

27
Q

Myasthenia Gravis (Autoimmune)

A

Antibody Mediated

Target Antigen: Acetylcholine receptor

Mechanism: Antibody blocks binding of ACh to the receptor (AKA nerves cannot connect to muscle cell, causing weakness in skeletal muscles)

28
Q

Graves’ Disease (autoimmune)

A

Antibody Mediated

Target Antigen: TSH receptor

Mechanism: Antibody mediated stimulation of TSH receptor (too much thyroid hormones=hyperthyroidism)

29
Q

Type I Diabetes (autoimmune)

A

T Cell Mediated

Target Antigen: Pancreatic beta-cells

Mechanism: Destroys beta-cells

30
Q

Goal of immunotherapies for autoimmune disease

A

REDUCE symptoms and PRESERVE organ function

Drug Goals: Monoclonal Ab, CTLA4, Regulatory Cytokines, Restoration of tolerance (biotherapeutics pretty much)